Projects funded by the NCN

Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Joanna Monika Wierońska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

Anticancer activity of the thiosemicarbazone derivatives

Call: SONATA 7 , Panel: NZ7

Principal investigator: dr Anna Dominika Mrozek-Wilczkiewicz

Uniwersytet Śląski w Katowicach, Wydział Matematyki, Fizyki i Chemii

In vitro assessment of selected protumorigenic effects favoring breast cancer development after exposure to silver nanop...

Call: OPUS 4 , Panel: NZ7

Principal investigator: dr hab. Maciej Marek Stępnik

Instytut Medycyny Pracy im. prof. dr. med. Jerzego Nofera

The influence of some selected antiepileptic drugs in combination with arachinodyl-2-chlorethylamide, a selective cannab...

Call: OPUS 3 , Panel: NZ7

Principal investigator: dr Marta Andres-Mach

Instytut Medycyny Wsi im. Witolda Chodźki

Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer ...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Anna Kawiak

Uniwersytet Gdański

"Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

Call: OPUS 28 , Panel: NZ7

Principal investigator: prof. Gabriel Piotr Nowak

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils...

Call: PRELUDIUM 1 , Panel: NZ6

Principal investigator: Aleksandra Budzyńska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit...

Call: SONATA 18 , Panel: NZ7

Principal investigator: dr Łukasz Kuryk

Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy

Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D...

Call: PRELUDIUM 21 , Panel: NZ7

Principal investigator: Kinga Maria Czarnota-Łydka

Uniwersytet Jagielloński, Collegium Medicum

Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

Call: SONATA 17 , Panel: NZ7

Principal investigator: dr Monika Anna Musiał-Kulik

Centrum Materiałów Polimerowych i Węglowych Polskiej Akademii Nauk

Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor...

Call: OPUS 21 , Panel: NZ7

Principal investigator: prof. Barbara Malinowska

Uniwersytet Medyczny w Białymstoku

In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

Call: OPUS 20 , Panel: NZ7

Principal investigator: dr Joanna Elżbieta Zawacka-Pankau

Warszawski Uniwersytet Medyczny

A novel approach based on the optimized multidrug combination for glioblastoma treatment.

Call: SONATA 16 , Panel: NZ7

Principal investigator: prof. Małgorzata Kucińska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Systems of polyphenols with prebiotic carriers as combinations with unknown potential of biological activity

Call: PRELUDIUM BIS 2 , Panel: NZ7

Principal investigator: prof. Judyta Agnieszka Cielecka-Piontek

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Combination of Molecular Simulation and Deep Learning for De Novo Drug Design

Call: PRELUDIUM 19 , Panel: ST6

Principal investigator: dr Tomasz Jakub Danel

Uniwersytet Jagielloński, Wydział Matematyki i Informatyki

Study on metabolism of microorganisms treated with metal nanoparticles, antibiotics, metal ions and their combinations u...

Call: PRELUDIUM 13 , Panel: ST4

Principal investigator: Agnieszka Maria Rogowska

Uniwersytet Mikołaja Kopernika w Toruniu, Wydział Chemii

Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr Anna Woziwodzka

Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

Call: OPUS 11 , Panel: NZ7

Principal investigator: dr Małgorzata Firczuk

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Modeling the relationship between structural features of modified TiO2 NPs and their cytotoxicity in vitro via a combina...

Call: PRELUDIUM 10 , Panel: NZ7

Principal investigator: Alicja Mikołajczyk

Uniwersytet Gdański, Wydział Chemii

The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

Call: PRELUDIUM 9 , Panel: NZ3

Principal investigator: Alicja Patrycja Pawlak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk